Update on the National Vaccine Injury Compensation Program

Journal of Emergency Medicine

Volumn 33, Issue 2, 2007, Pages 199-211

  Edlich, Richard F ^a,b   Olson, Dana M ^c   Olson, Brianna M ^c   Greene, Jill Amanda ^b   Gubler, K Dean ^b   Winters, Kathryne L ^d   Kelley, Angela R ^c   Britt, L D ^e   Long III, William B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LEGACY EMANUEL HOSPITAL   (United States)

^c Washington State University Vancouver ^*

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e LLP   (United States)

Author keywords

thimerosal; Vaccine Injury Compensation Program

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; VACCINE;

ARTICLE; AUTISM; COMPENSATION; DEATH; DRUG INDUCED DISEASE; HEALTH PROGRAM; HUMAN; MEDICAL RECORD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SAFETY; STATISTICS; TIME SERIES ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COMPENSATION AND REDRESS; HUMANS; INFANT; MANDATORY PROGRAMS; MASS VACCINATION; PATIENT EDUCATION AS TOPIC; PATIENT RIGHTS; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; TRUTH DISCLOSURE; UNITED STATES; VACCINES;

EID: 34547663416     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.01.001     Document Type: Article

References (15)

1. Davis T.C., Fredrickson D.D., Kennen E.M., et al. Childhood vaccine risk/benefit communication among public health clinics: a time-motion study. Public Health Nurs 21 (2004) 228-236
2. Edlich R.F., Martin M.L., Foley M.L., et al. Vaccine information statements. Revolutionary but neglected educational advances in healthcare in the United States. J Long Term Eff Med Implants 15 (2005) 91-114
3. National Childhood Vaccine Injury Act Vaccine Injury Table. Available at. http://www.hrsa.gov/vaccinecompensation/table.htm. Accessed 2006.
4. Blaxill M.F. What's going on?. The question of time trends in autism. Public Heath Rep 119 (2004) 536-551
5. Gerlai R., and Gerlai J. Autism: a target of pharmacotherapies?. Drug Discov Today 9 (2004) 366-374
6. Gerlai J., and Gerlai R. Autism: a large unmet medical need and a complex research problem. Physiol Behav 79 (2003) 461-470
7. Bertrand J., Mars A., Boyle C., Bove F., Yeargin-Allsopp M., and Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108 (2001) 1155-1161
8. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., and Murphy C. Prevalence of autism in a US metropolitan area. JAMA 289 (2003) 49-55
9. California Department of Developmental Services. Autistic Spectrum Disorders-Changes in the California Caseload-An Update 1999 through 2002 (2003), State of California, Sacramento, CA
10. Ball L.K., Ball R., and Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics 107 (2001) 1147-1154
11. Bernard S., Enayati A., Redwood L., Roger H., and Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses 56 (2001) 462-471
12. Bernard S., Enayati A., Roger H., Binstock T., and Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry 7 Suppl 2 (2002) S42-S43
13. Blaxill M.F., Redwood L., and Bernard S. Thimerosal and autism?. A plausible hypothesis that should not be dismissed. Med Hypotheses 62 (2004) 788-794
14. Geier D.A., and Geier M.R. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 11 (2005) CR160-CR170
15. Vaccine Compensation Statistics Table. Available at. http://www.hrsa.gov/vaccinecompensation/statistics_report.htm#post_1988.